Article info
Case report
Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report
- Correspondence to Estela García-Martín, Department of Pharmacy, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, 28007, Spain; egarciamartin{at}salud.madrid.org
Citation
Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report
Publication history
- Received May 8, 2017
- Accepted August 1, 2017
- First published August 16, 2017.
Online issue publication
May 01, 2020
Article Versions
- Previous version (28 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.